Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04047758
What this trial is testing

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 420
Not applicableStudy completedNCT01874548
What this trial is testing

MR Metabolic Biomarkers for Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Chang Gung Memorial Hospital 136
Large-scale testing (Phase 3)Study completedNCT01651949
What this trial is testing

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Who this might be right for
Genital WartsAnal CancerAnal Intraepithelial Neoplasia
Merck Sharp & Dohme LLC 2,520
Large-scale testing (Phase 3)Looking for participantsNCT07164443
What this trial is testing

Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC 1,203
Testing effectiveness (Phase 2)Study completedNCT00693615
What this trial is testing

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 60
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Early research (Phase 1)Looking for participantsNCT07224425
What this trial is testing

BI 3810944 in Patients With Advanced Cancer

Who this might be right for
Solid TumoursMelanoma
Boehringer Ingelheim 69
Testing effectiveness (Phase 2)Study completedNCT01757392
What this trial is testing

Candin Safety & Efficacy Study for the Treatment of Warts

Who this might be right for
WartsHuman Papilloma Virus
Nielsen BioSciences, Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT02152956
What this trial is testing

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Who this might be right for
AML
MacroGenics 244
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Large-scale testing (Phase 3)Study completedNCT02893254
What this trial is testing

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

Who this might be right for
AS
Innovent Biologics (Suzhou) Co. Ltd. 438
Large-scale testing (Phase 3)Study completedNCT02019277
What this trial is testing

Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT00136422
What this trial is testing

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplasia
Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT05936502
What this trial is testing

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaExtranodal ExtensionHuman Papilloma Virus Related Carcinoma
Head and Neck Cancer International Group 3,500
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableStudy completedNCT01729429
What this trial is testing

An Intervention Promoting HPV Vaccination in Safety-net Clinics

Who this might be right for
Human Papilloma Virus-Related Cervical Carcinoma
University of Texas Southwestern Medical Center 831
Very early researchStudy completedNCT07299253
What this trial is testing

Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06

Who this might be right for
Metastatic Solid Tumors (Any Localization)
Lanzhou University Second Hospital 5
Testing effectiveness (Phase 2)Ended earlyNCT06018129
What this trial is testing

A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNon-Hodgkin Lymphoma
Genmab 9
Not applicableLooking for participantsNCT00033137
What this trial is testing

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Who this might be right for
Kidney NeoplasmsKidney CancerPneumothorax+1 more
National Cancer Institute (NCI) 950
Next Page